| Names | |
|---|---|
| IUPAC name
2-(Acetylamino)-2-deoxy-D-galactose | |
| Other names
GalNAc; 2-Acetamido-2-deoxy-D-galactose; N-Acetylchondrosamine; 2-Acetamido-2-deoxy-D-galactopyranose; N-Acetyl-D-galactosamine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C8H15NO6 | |
| Molar mass | 221.21 g/mol |
| Melting point | 172 to 173 °C (342 to 343 °F; 445 to 446 K) |
| Related compounds | |
Related monosaccharides |
N-Acetylglucosamine Galactosamine Galactose |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
N-Acetylgalactosamine (GalNAc), is an amino sugar derivative of galactose.
In humans it is the terminal carbohydrate forming the antigen of blood group A.
It is typically the first monosaccharide that connects serine or threonine in particular forms of protein O-glycosylation.
N-Acetylgalactosamine is necessary for intercellular communication, and is concentrated in sensory nerve structures of both humans and animals.
GalNAc is also used as a targeting ligand in investigational antisense oligonucleotides and siRNA therapies targeted to the liver, where it binds to the asialoglycoprotein receptors on hepatocytes.